Resource implications of bortezomib therapy in a large UK cohort: An evaluation study.
Faouzi DjebbariMaciej TatarczuchFotios PanitsasGrant VallanceManuela SultanovaJaimal KothariKarthik RamasamyAndy PeniketPublished in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2019)
Our real-world resource analysis demonstrated that delivering bortezomib therapy can be associated with significant cost and time implications for patients and healthcare providers. Our study method sets a basis for evaluating resource implications of other novel approaches to myeloma therapy.